Lonza
Arvind Patil is an experienced professional in program management within the medical device and biotechnology sectors, currently serving as Associate Director of Program Management at Lonza since April 2022. Previously, Arvind held the position of Associate Director and Head of CMC Program Management at Adagene from March 2021 to March 2022, focusing on advancing cancer therapeutics. Earlier roles at Lonza included Senior Program Manager for both late-stage and early-stage clinical projects, while experience at Lombard Medical Technologies encompassed program management for new product introductions in Class III medical devices. Arvind's foundational experience includes positions at Vascutek Ltd and TWI, specializing in product development and technology transfer, respectively. Educational qualifications include a Post Graduate Certificate in Clinical Trial Management from Parexel Academy and a Master's degree in Engineering from the University of Bath, complemented by a Diploma in Management from the Chartered Management Institute.
This person is not in the org chart
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.